This week we’re speaking with a woman who’s on a mission to make other women, “really f***ing rich.” And who doesn’t like the sound of that? Cindy Eckert, founder and CEO of Sprout Pharmaceuticals is leading this charge, while simultaneously supercharging our sex lives. Her company — which she sold for $1 billion and bought back for practically nothing — created Addyi, the first ever FDA-approved drug for low sexual desire in women.
We talk hormones, big pharma, negotiations and how to handle sexism. Her strategy: “Kill them with competence.” It’s a must-listen. In Mailbag, we dive into credit cards, student loans and other financial trade-offs. And, in Thrive, we discuss troubling research on the big little lies we tell when women outearn their husbands.
Sponsored by Fidelity Investments. Join us for Moms & Money, a candid conversation with moms about this past year and beyond. We’ll talk about the unique financial realities moms face and how you can create a roadmap for your family’s financial future. Visit Fidelity.com/Women today.